Biomaterial-Enhanced Cell and Drug Delivery: Lessons Learned in the Cardiac Field and Future Perspectives

Hugh S O'Neill, Laura B Gallagher, Janice O'Sullivan, William Whyte, Clive Curley, Eimear Dolan, Aamir Hameed, Joanne O'Dwyer, Christina Payne, Daniel O'Reilly, Eduardo Ruiz-Hernandez, Ellen T Roche, Fergal J O'Brien, Sally Ann Cryan, Helena Kelly, Bruce Murphy, Garry P Duffy

Research output: Contribution to a Journal (Peer & Non Peer)Review articlepeer-review

Abstract

Heart failure is a significant clinical issue. It is the cause of enormous healthcare costs worldwide and results in significant morbidity and mortality. Cardiac regenerative therapy has progressed considerably from clinical and preclinical studies delivering simple suspensions of cells, macromolecule, and small molecules to more advanced delivery methods utilizing biomaterial scaffolds as depots for localized targeted delivery to the damaged and ischemic myocardium. Here, regenerative strategies for cardiac tissue engineering with a focus on advanced delivery strategies and the use of multimodal therapeutic strategies are reviewed.

Original languageEnglish
Pages (from-to)5648-61
Number of pages14
JournalAdvanced Materials
Volume28
Issue number27
DOIs
Publication statusPublished - Jul 2016
Externally publishedYes

Keywords

  • Biocompatible Materials
  • Drug Delivery Systems
  • Heart
  • Tissue Engineering
  • Tissue Scaffolds

Fingerprint

Dive into the research topics of 'Biomaterial-Enhanced Cell and Drug Delivery: Lessons Learned in the Cardiac Field and Future Perspectives'. Together they form a unique fingerprint.

Cite this